Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("RAUH, Daniel")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 13 of 13

  • Page / 1
Export

Selection :

  • and

New cyanopeptide-derived low molecular weight thrombin inhibitorsRADAU, Gregor; GEBEL, Jana; RAUH, Daniel et al.Archiv der Pharmazie (Weinheim). 2003, Vol 336, Num 8, pp 372-380, issn 0365-6233, 9 p.Article

Using small molecules to target protein phosphatasesVINTONYAK, Viktor V; WALDMANN, Herbert; RAUH, Daniel et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 7, pp 2145-2155, issn 0968-0896, 11 p.Article

Epidermal Growth Factor Receptor (EGFR) Signaling and Covalent EGFR Inhibition in Lung CancerHEUCKMANN, Johannes M; RAUH, Daniel; THOMAS, Roman K et al.Journal of clinical oncology. 2012, Vol 30, Num 27, pp 3417-3420, issn 0732-183X, 4 p.Article

Hybrid Compound Design To Overcome the Gatekeeper T338M Mutation in cSrc#GETLIK, Matthaus; GRÜTTER, Christian; SIMARD, Jeffrey R et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 13, pp 3915-3926, issn 0022-2623, 12 p.Article

Enantioselective synthesis of the spirotryprostatin A scaffoldANTONCHICK, Andrey P; SCHUSTER, Hannah; BRUSS, Hanna et al.Tetrahedron (Oxford. Print). 2011, Vol 67, Num 52, issn 0040-4020, 10056, 10195-10202 [9 p.]Article

ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK InhibitorsHEUCKMANN, Johannes M; HÖLZEL, Michael; RAUH, Daniel et al.Clinical cancer research (Print). 2011, Vol 17, Num 23, pp 7394-7401, issn 1078-0432, 8 p.Article

Structural insights into how irreversible inhibitors can overcome drug resistance in EGFRMICHALCZYK, Anja; KLÜTER, Sabine; RODE, Haridas B et al.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 7, pp 3482-3488, issn 0968-0896, 7 p.Article

Identification and further development of thiazolidinones spiro-fused to indolin-2-ones as potent and selective inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase BVINTONYAK, Viktor V; WARBURG, Karin; OVER, Björn et al.Tetrahedron (Oxford. Print). 2011, Vol 67, Num 35, issn 0040-4020, 6413, 6713-6729 [18 p.]Article

Displacement Assay for the Detection of Stabilizers of Inactive Kinase ConformationstKLÜTER, Sabine; GRÜTTER, Christian; NAQVI, Tabassum et al.Journal of medicinal chemistry (Print). 2010, Vol 53, Num 1, pp 357-367, issn 0022-2623, 11 p.Article

ATP competitive inhibitors of D-alanine-D-alanine ligase based on protein kinase inhibitor scaffolds : Tetrahedron Young Investigator Award 2004TRIOLA, Gemma; WETZEL, Stefan; ELLINGER, Bernhard et al.Bioorganic & medicinal chemistry. 2009, Vol 17, Num 3, pp 1079-1087, issn 0968-0896, 9 p.Article

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancerPEIFER, Martin; FERNANDEZ-CUESTA, Lynnette; MENON, Roopika et al.Nature genetics. 2012, Vol 44, Num 10, pp 1104-1110, issn 1061-4036, 7 p.Article

Structure-based design, synthesis and biological evaluation of N-pyrazole, N'-thiazole urea inhibitors of MAP kinase p38αGETLIK, Matthaus; GRÜTTER, Christian; SIMARD, Jeffrey R et al.European journal of medicinal chemistry. 2012, Vol 48, pp 1-15, issn 0223-5234, 15 p.Article

Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance MutationSOS, Martin L; RODE, Haridas B; RUDDIGKEIT, Lars et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 3, pp 868-874, issn 0008-5472, 7 p.Article

  • Page / 1